Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
RSS icon

How Blue Cross of Idaho's new plans bring back pre-ACA insurance design

Weeks after Idaho announced it would allow the sale of insurance plans that don’t comply with Affordable Care Act (ACA) regulations, an insurer will offer coverage which violates the existing law.

5 best practices for transitioning to the cloud

Transitioning to a cloud-based system brings many benefits—but only if the technology is implemented and utilized with methods that lead to optimization. In a recent post by MeriTalk, authors outlined the five best practices for organizations making the move to the cloud.

Scientists create lab-grown kidney tissue capable of producing urine

Scientists from the University of Manchester in the U.K. have developed human kidney tissue in a lab capable of producing urine once implanted into a mouse. Findings were published in Stem Cell Reports.

Thumbnail

Organ-on-chip technology shows activity of hepatitis B virus

Scientists at Imperial College London have developed and tested an organ-on-a-chip showing how pathogens like hepatitis B interact with artificial human organs. Findings were published in Nature Communications.

Children’s National Health System integrates mobile query system in EHRs

Children’s National Health System has chosen Artifact Health’s mobile physician query solution to improve their quality of patient records and ensure full reimbursement.

Researchers find implanted continuous glucose sensor safe, accurate

An implantable continuous glucose monitor was shown to be safe and accurate in patients with type 1 and 2 diabetes, according to a study published in Diabetes Technology & Therapeutics.

Seizure detection smartwatch receives FDA clearance

Empatica Inc. has received FDA clearance for Embrace, an artificial intelligence (AI)-powered smartwatch capable of detecting seizures.

Thumbnail

Purdue Pharma, producer of OxyContin, stops promoting opioids to physicians

Purdue Pharma, best known for making and selling OxyContin, announced Feb. 10 that it will stop marketing opioid drugs to physicians. The company also stated it will lay off half of its sales force, with the remaining staff of 200 focusing on other medications.

Displaying 1473 - 1480 of 3584

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup